News & Events 2022
1 January
Incepta Proudly Introduces Tolosa 80
Tocilizumab 80 mg
First ever global biosimilar of Tocilizumab
Emergency Use Authorization
To control the cytokine storm in COVID-19 patients.
Incepta Proudly Introduces Tolosa 80
Tocilizumab 80 mg
First ever global biosimilar of Tocilizumab
Emergency Use Authorization
To control the cytokine storm in COVID-19 patients.
